Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

CSE/EPIC stock hub

CSE/EPIC has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

CSE/EPICis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

17.7M

Canadian Securities Exchange

Market data

Live price

Current market quote for this ticker.

Current price

CSE/EPIC

In the news

Latest news · CSE/EPIC

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 11P50 15.6P75 25.4

Trailing P/E4.9

P25 7.4P50 15.6P75 34.3

ROE13.9

P25 -121.5P50 -40.9P75 0.5

ROIC6.5

P25 -72.5P50 -16P75 1.4

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All CSE/EPIC market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

199

Groups with data

Currency

CAD

Showing 199 of 199 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	Canada
Country code	CA
Enterprise value	CAD 9.7M
Exchange	Canadian Securities Exchange
Financial currency	CAD
First seen	2026-05-10
Industry	Drug Manufacturers - Specialty & Generic
Isin	CA68237A1093
Last refreshed	2026-05-10
Market cap	CAD 17.7M
Price	CAD 0.15
Price currency	CAD
Sector	Healthcare
Sic	2834
Symbol	cse/EPIC
Website	https://1cminc.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	24.47%
EV Earnings	2.25x
EV/EBIT	4.84x
EV/EBITDA	3.52x
EV/FCF	5.13x
EV/Sales	0.13x
FCF yield	10.75%
P/B ratio	0.53x
P/E ratio	4.91x
P/S ratio	0.24x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	2.68%
EBITDA Margin	3.18%
FCF margin	2.53%
Gross margin	21.03%
Gross Profit	CAD 15.8M
Gross Profit Growth	18.61%
Gross Profit Growth Q	-2.83%
Gross Profit Growth3 Y	76.91%
Net Income	CAD 4.3M
Net Income Growth	157.19%
Net Income Growth Q	1,547%
Net Income Growth Quarters	2%
Net Income Growth Years	0%
Pretax Margin	6.79%
Profit Margin	5.76%
Profitable Years	2
ROA	2.98
Roa5y	-7.72
ROCE	5.69
ROE	13.91
ROIC	6.54
Roic5y	-14.92

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	25.9%
Cagr1y	-40.02%
Cagr3y	-54.56%
Cagr5y	-24.22%
EPS Growth	65.7
EPS Growth Q	1,385.1
EPS Growth Quarters	2
EPS Growth Years	0
FCF Growth	-51.26%
FCF Growth Q	793.55%
OCF Growth	-41.18%
OCF Growth Q	811.41%
Revenue Growth	12.06x
Revenue Growth Q	0.2x
Revenue Growth Quarters	18x
Revenue Growth Years	5x
Revenue Growth3 Y	69.49x
Revenue Growth5 Y	217.62x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	CAD 1.78
Assets	CAD 44.1M
Cash	CAD 9.5M
Current Assets	CAD 36.7M
Current Liabilities	CAD 8.7M
Debt	CAD 1.6M
Debt EBITDA	CAD 0.56
Debt Equity	CAD 0.05
Debt FCF	CAD 0.82
Equity	CAD 33.4M
Interest Coverage	2.48
Liabilities	CAD 10.7M
Long Term Assets	CAD 7.4M
Long Term Liabilities	CAD 2M
Net Cash	CAD 7.9M
Net Cash By Market Cap	CAD 44.83
Net Debt EBITDA	CAD -3.32
Net Debt Equity	CAD -0.24
Net Debt FCF	CAD -4.17
Tangible Book Value	CAD 28.8M
Tangible Book Value Per Share	CAD 0.22
WACC	14.87

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.2
Inventory Turnover	21.26
Net Working Capital	CAD 18.6M
Quick ratio	1.23
Working Capital	CAD 28M
Working Capital Turnover	CAD 4.3

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-55.22%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	900%
1Y total return	-40%
200-day SMA	0.57
3Y total return	-90.63%
50-day SMA	0.19
50-day SMA vs 200-day SMA	50under200
5Y total return	-75%
All Time High	2.5
All Time High Change	-94%
All Time High Date	2023-11-09
All Time Low	0.01
All Time Low Change	2,900%
All Time Low Date	2015-12-24
ATR	0.02
Beta	1.46
Beta1y	1.66
Beta2y	0.89
Ch YTD	-23.08
High	0.15
High52	0.5
High52 Date	2025-09-09
High52ch	-69.7%
Low	0.15
Low52	0.12
Low52 Date	2026-03-13
Low52ch	25%
Ma50ch	-21.88%
Price vs 200-day SMA	-73.73%
RSI	46.45
RSI Monthly	37.23
RSI Weekly	33.4
Sharpe ratio	0.41x
Sortino ratio	0.79
Total Return	-55.22%
Tr YTD	-23.08
Tr1m	-14.29%
Tr1w	3.45%
Tr3m	-16.67%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	CAD 2M
Operating Income Growth	-27.79
Operating Income Growth Q	22.84
Operating margin	2.68

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	102,726,935%
Net Borrowing	-2,981,707
Shares Insiders	12.75%
Shares Out	117,736,935
Shares Qo Q	10.93%
Shares Yo Y	55.22%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	CAD 1.6M
Average Volume	6,979.65x
Bv Per Share	0.26
CAPEX	CAD -523,250
Ch10y	900
Ch1m	-14.29
Ch1w	3.45
Ch1y	-40
Ch3m	-16.67
Ch3y	-90.63
Ch5y	-75
Ch6m	-67.03
Change	3.45%
Change From Open	0
Close	0.15
Days Gap	3.45
Depreciation Amortization	372,490
Dollar Volume	150
Earnings Date	2026-07-27
EBIT	CAD 2M
EBITDA	CAD 2.4M
EPS	CAD 0.03
F Score	6
FCF	CAD 1.9M
FCF EV Yield	19.48x
FCF Per Share	CAD 0.02
Financing CF	-2,981,707
Fiscal Year End	August
Graham Number	0.41923
Graham Upside	179.5
Income Tax	CAD 771,487
Investing CF	2,251,010
Is Primary Listing	1
Last Earnings Date	2026-01-29
Last Report Date	2026-02-28
Ma150	0.35
Ma150ch	-56.67%
Ma20	0.16
Ma20ch	-4.64%
Net CF	1,690,380
Next Earnings Date	2026-07-27
Open	0.15
P FCF Ratio	9.31
P OCF Ratio	7.29
Ppne	2,790,354
Price Date	2026-05-05
Price EBITDA	CAD 7.41
Ptbv Ratio	0.61
Relative Volume	0.14x
Revenue	75,041,772x
SBC By Revenue	0.44x
Share Based Comp	332,596
Tax By Revenue	1.03x
Tax Rate	15.15%
Tr6m	-67.03%
Volume	1,000

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does CSE/EPIC pay a dividend?

Capital-return profile for this ticker.

Performance

CSE/EPIC stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns CSE/EPIC?

Insider, institutional, and short-interest positioning.

Institutional ownership

n/a

Share of float held by funds and institutions

Insider ownership

+12.7%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+55.2%

Negative means the company is buying back shares.

Technical

CSE/EPIC momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

46.4

Neutral momentum band

Price vs 200-day MA

-73.7%

50/200-day relationship not available

Beta (5Y)

1.46

More volatile than the market

Sharpe ratio

0.41

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About CSE/EPIC

Hub-level FAQ points readers to the deeper analysis pages.

What is the current cse/EPIC stock rating?

cse/EPIC is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full cse/EPIC analysis?

The full report lives at /stocks/cse/EPIC/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for cse/EPIC?

The latest report frames cse/EPIC around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the cse/EPIC page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.